स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - candida parapsilosis, d12, 0.33 ml / 1ml; penicillium festgestellt, d12, 0.33 ml / 1ml; aspergillus einzigartigen schwarz, d12, 0.33 ml / 1ml - tropfen / spray - d - candida parapsilosis, d12, 0,33 ml / 1 ml; penicillium noté, d12, 0,33 ml / 1 ml; aspergillus noir unique, d12, 0,33 ml / 1 ml - homöopathisch

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - candida albicans d 12, 0,33 mg / 1 ml; candida parapsilosis, d12, 0,33 mg / 1 ml; penicillium roqueforti, d12, 0,33 mg / 1 ml - tropfen / spray - d - candida albicans, d12, 0,33 ml / 1 ml; candida parapsilosis, d12, 0,33 ml / 1 ml; penicillium roqueforti, d12, 0,33 ml / 1 ml - homöopathisch

स्विट्ज़रलैंड - फ़्रेंच - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - candida albicans e volumine cellulae (lyophil., steril.) d5 (hab 5a), candida parapsilosis e volumine cellulae (lyophil., steril.) d5 (hab 5a), penicillium roqueforti e volumine cellulae (lyophil., steril.) d5 (hab 5a) - buvable en gouttes et frotter - zulassung gilt auch für alle höheren folgepotenzen: candida albicans e volumine cellulae (lyophil., steril.) d5 (hab 5a) 0.334 ml, candida parapsilosis e volumine cellulae (lyophil., steril.) d5 (hab 5a) 0.334 ml, penicillium roqueforti e volumine cellulae (lyophil., steril.) d5 (hab 5a) 0.334 ml, aqua purificata, ad solutionem pro 1 ml, corresp. 22 guttae. - zulassung mit reduziertem dossier ohne indikation nach art. 25 abs. 1 kpav (sr 812.212.24) - les médicaments homéopathiques